QSAR of aminopyrido[2,3-d]pyrimidin-7-yl derivatives: Anticancer drug design by computed descriptors

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 24, Issue 4, 2009, Pages 937-948

  Nandi, Sisir ^a   Bagchi, Manish C ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

anticancer drug design; inhibition; murine tumors; pyrido pyrimidine derivatives; QSAR; ridge regression; structural descriptors; tyrosine kinase

Indexed keywords

ANTINEOPLASTIC AGENT; PYRIDINE DERIVATIVE; PYRIMIDINONE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; DRUG DESIGN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTINEOPLASTIC AGENTS; COMPUTER SIMULATION; DRUG DESIGN; MOLECULAR STRUCTURE; PYRIDINES; PYRIMIDINONES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 76249106216     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360802519327     Document Type: Article

References (38)

1. Hamby JM, Connolly CJC, Schroeder MC, Winters RT, Showalter HDH, Panek RL, Major TC, Olsewski B, Ryan MJ, Dahring T, Lu GH, Keiser J, Amar A, Shen C, Kraker AJ, Slintak V, Nelson JM, Fry DW, Bradford L, Hallak H, Doherty AM. Structure-Activity Relationships for a Novel Series of Pyrido[2,3-d]pyrimidine Tyrosine Kinase Inhibitors. J Med Chem 1997; 40: 2296 – 2303.
2. Blume-Jensen P, Hunter T. Oncogenic kinase signaling. Nature 2001; 411: 355 – 365.
3. Klutchko SR, Hamby JM, Boschelli DH, Wu Z, Kraker AJ, Amar AM, Hartl BG, Shen C, Klohs WD, Steinkampf RW, Driscoll DL, Nelson JM, Elliott WL, Roberts BJ, Stoner CL, Vincent PW, Dykes DJ, Panek RL, Lu GH, Major TC, Dahring TK, Hallak H, Bradford LA, Showalter HDH, Doherty AM. 2-Substituted Aminopyrido[2,3-d]pyrimidin-7(8H)-ones. Structure-Activity Relationships Against Selected Tyrosine Kinases and in Vitro and in Vivo Anticancer Activity. J Med Chem 1998; 41: 3276 – 3292.
4. Bridges AJ, Zhou H, Sercel AD, McMichael A, Fry DW. Tyrosine Kinase Inhibitors. 16. 6,5,6-Tricyclic Benzothieno[3,2-d]pyrimidines and Pyrimido[5,4-b]- and -[4,5-b]indoles as Potent Inhibitors of the Epidermal Growth Factor Receptor Tyrosine Kinase. J Med Chem 1999; 42: 5464 – 5474.
5. Schroeder MC, Hamby JM, Connolly CJC, Grohar PJ, Winters RT, Barvian MR, Moore CW, Boushelle SL, Crean SM, Kraker AJ, Driscoll DL, Vincent PW, Elliott WL, Lu GH, Batley BL, Dahring TK, Major TC, Panek RL, Doherty AM, Showalter HDH. Soluble 2-Substituted Aminopyrido[2,3-d]pyrimidin-7-yl Ureas. Structure-Activity Relationships against Selected Tyrosine Kinases and Exploration of in Vitro and in Vivo Anticancer Activity. J Med Chem 2001; 44: 1915 – 1926.
6. Bagchi MC, Maiti BC, Mills D, Basak SC. Usefulness of graphical invariants in quantitative structure–activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type. J Mol Model 2004; 10: 102 – 111.
7. Bagchi MC, Maiti BC. On application of atom pairs on Drug Design. J Mol Struct: THEOCHEM 2003; 623: 31 – 37.
8. Bagchi MC, Maiti BC, Bose S. QSAR of antituberculosis drugs of INH type using graphical invariants. J Mol Struct: THEOCHEM 2004; 679: 179 – 186.
9. Nandi S, Bagchi MC. QSAR analysis of BABQ compounds via calculated molecular descriptors. Med Chem Res 2007; 15: 393 – 406.
10. Nandi S, Vracko M, Bagchi MC. Anticancer activity of selective phenolic compounds: QSAR studies using ridge regression and neural networks. Chem Biol Drug Des 2007; 70: 424 – 436.
11. Ghosh P, Thanadath M, Bagchi MC. On an aspect of calculated molecular descriptors in QSAR studies of quinolone antibacterials. Molecular Diversity 2006; 10: 415 – 427.
12. Hoerl AE, Kennard RW. Ridge regression biased estimation for nonorthogonal problems. Technometrics 1970; 8: 27 – 51.
13. Ajmani S, Jadhav K, Kulkarni SA. Three-Dimensional QSAR using the k-Nearest Neighbor method and its interpretation. J Chem Inf Model 2006; 46: 24 – 31.
14. Basak SC, Mills D, Hawkins DM, EI-Masri HA. Prediction of tissue:air partition coefficient: A comparison of structure-based and property-based methods. SAR QSAR Environ Res 2002; 13: 649 – 665.
15. Basak SC, Grunwald GD Niemi GJ. In: A.T. Balaban (Ed.). From Chemical Topology To Three-Dimensional Geometry. New York: Plenum Press; 1997. p 73 – 116.
16. http:// preadmet.brdrc.org/
17. Molecular Design Suite 3.5, VLife Technologies, Pune, India. www.vlifesciences.com
18. Roy K. Topological descriptors in drug design and modeling studies. Molecular Diversity 2004; 8: 321 – 323.
19. Katritzky AR, Petrukhin R, Tatham D, Basak S, Benfenati E, Karelson M, Maran U. Interpretation of quantitative structure–property and–activity relationships. J Chem Inf Comput Sci 2001; 41: 679 – 685.
20. Rao CR. Linear Statistical Inference and Its Applications (2nd ed.). New York: Wiley; 1973.
21. Randic M. Novel shape descriptors for molecular graphs. J Chem Inf Comput Sci 2001; 41: 607 – 613.
22. Rencher AC, Pun FC. Inflation of R2 in best subset regression. Technometrics 1980; 22: 49 – 53.
23. Estrada E. In: J Devillers and AT Balaban (Eds.). Topological Indices And Related Descriptors In QSAR And QSPR. Amsterdam, The Netherlands: Gordon and Breach; 1999. p 403 – 453.
24. Wold H. Soft modelling by latent variables: The non-linear iterative partial least squares approach. In: Gani J. (ed.). Perspectives in probability and statistics. papers in honor of Bartlett MS. London: Academic Press; 1975.
25. Hoskuldsson A. A Combined Theory for PCA and PLS. J Chemom 1995; 9: 91 – 123.
26. Massy WF. Principal Components Regression in Exploratory Statistical Research. J. Amer Statist Assoc 1965; 60: 234 – 246.
27. Frank IE, Friedman JH. A Statistical View of Some Chemometrics Regression Tools. Technometrics 1993; 35: 109 – 135.
28. Halgren, TA. Merck Molecular Force Field. III. Molecular Geometries and Vibrational Frequencies. J Comp Chem 1996; 17: 553 – 586.
29. Cramer RD, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA) 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 1988; 110: 5959 – 5967.
30. Gasteiger J, Marsili M. Iterative Partial Equalization of Orbital Electronegativity - A Rapid Access to Atomic Charges. Tetrahedron 1980; 36: 3219 – 3228.
31. Leach AR, Gillet VJ. An Introduction to Chemoinformatics., Boston: Kluwer Academic Publishers; 2003. p 80 – 100.
32. Leach AR. Molecular Modelling: Principles and Applications. Henry Ling, London; 2001. p 695.
33. NCSS – Statistical and Power Analysis Software; Hintze J. 2004, NCSS and PASS. Number Cruncher Statitical Systems, Kaysville, Utah. http://www.ncss.com/.
34. Bagchi MC, Mills D, Basak SC. Quantitative structure-activity relationship (QSAR) studies of quinolone antibacterials against M. fortuitum and M. smegmatis using theoretical molecular descriptors. J Mol Model 2007; 13: 111 – 120.
35. Hudson BD, Hyde RM, Rahr E, Wood J. Parameter based methods for compound selection from chemical databases. Quant Struct Activity Relationships 1996; 15: 285 – 289.
36. Kubinyi H. Ed. 3D QSAR in Drug Design. Theory, Methods and Applications. ESCOM, Leiden: Science Publishers B.V.; 1993. p 486 – 502.
37. Samee W, Nunthanavanit P, Ungwitayatorn J. 3D-QSAR Investigation of Synthetic Antioxidant Chromone Derivatives by Molecular Field Analysis. Int J Mol Sci 2008; 9: 235 – 246.
38. Trumpp-Kallmeyer S, Rubin JR, Humblet C, Hamby JM, Showalter HDH. Development of a Binding Model to Protein Tyrosine Kinases for Substituted Pyrido[2,3-d]pyrimidine Inhibitors. J Med Chem 1998; 41: 1752 – 1763.